Results 261 to 270 of about 195,243 (312)

Study of the association between HDAC8, SIRT1, and P53 gene expression with drug resistance in chronic myeloid leukemia patients. [PDF]

BMC Cancer
Mansouri R, Heydarpour F, Yari K, Naseroleslami M, Payandeh M.   +4 more
europepmc   +1 more source

HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemia. [PDF]

Hemasphere
Toulemonde C, Dubois V, Bouvier C, Ridao A, Archier MC, Balsat M, Ducastelle S, Barraco F, Fossard G, Hildt J, Bollard J, Michallet M, Labussière-Wallet H, Hayette S, Nicolini FE, Alcazer V.   +15 more
europepmc   +1 more source

Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones

, 2013
Christophe Bonnet, Catherine Menten, Frédéric Lambert, André Gothot, Frédéric Baron, Jo Caers, Christian Herens, Yves Béguin   +7 more
openalex   +1 more source

Response Assessment of Generic Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Prospective Study from a Tertiary Care Centre in North Eastern India. [PDF]

Cureus
Choudhuri A, Bhattacharyya J, Das S, Das D, Dhameja N.   +4 more
europepmc   +1 more source

Global burden of leishmaniasis, 1990-2021: systematic analysis of the global burden of disease study. [PDF]

Int J Equity Health
Li S, Qiu T, Zhao N, Liu M, He X, Wang X, Jiang S, Luo M, Wang S, Zhang L, Wang X.   +10 more
europepmc   +1 more source

[Guideline for the diagnosis and treatment of chronic myeloid leukemia in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chinese Society of Hematology, Chinese Medical Association.   +1 more
europepmc   +1 more source

Potential differences between real-life and randomized controlled trial populations in chronic myeloid leukemia. [PDF]

Ann Hematol
Horňák T, Žáčková D, Mayer J.
europepmc   +1 more source

Cytogenetic profile of chronic myeloid leukaemia patients resistant to imatinib at tertiary level in Indonesia. [PDF]

Mol Cytogenet
Rinaldi I, Louisa M, Arwanih EY, Adibah FF, Kadharusman MM, Remifta Putra MA, Winston K, Shufiyani YM, Salma RA.   +8 more
europepmc   +1 more source

Body Mass Index influences Imatinib exposure in CML patients: evidence from TDM with adaptive dosing

Paul Maroselli, Raphaëlle Fanciullino, Julien Colle, Laure Farnault, Pauline Roché, Geoffroy Venton, Régis Costello, Joseph Ciccolini   +7 more
openalex   +2 more sources